Clinical trial costs are spiraling out of control. Recently completed studies have pegged the cost of bringing a new drug to market at from 500 to 800 million dollars. Data handling and pickup costs related to patient records account for a staggering 30 percent of drug development costs. Dig deeper into the issues Information Mediary has addressed in past reports and discover some further numbers on the cost of tracking non-compliance in clinical trials settings.

Consider the cost of recording dosing times, tempered with a good deal of uncertainty as to when medication was actually taken. Factor in the time spent deciphering often incomplete patient diaries, which are sometimes filled out in the waiting room just prior to the follow-up visit. Now imagine paying someone $4.00 per page for the double data entry required to capture that information into an eCRF.